Vaccitech Prepares For IPO, But AZ COVID-19 Vaccine Safety Fears Cloud Launch

Pipeline Candidates Use Same Platform

 
• By Andrew McConaghie
Nasdaq
Vaccitech is looking to join the biotech IPO boom, and is aiming to raise $100m with its NASDAQ debut.

More from Business

More from Scrip